Hall Mary Dean reported option exercise involving 5,871 derivative units of Magnera Corp at $0.00 for $0 on Nov 14, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Director
DIR
Filed Nov 16, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
5,871Restricted Stock Units
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
0Direct
Trade date
Nov 14, 2026Option exercise
Filed
Nov 16, 2026, 1:43 PM ET2-day reporting delay
Accession
0000041719-26-000072Code M · Transaction 401762
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 14, 2026Option exercise5,871$12.64$74,209.44Trade 401761
2 transaction rows in this filing. Joint filers share the same rows.

MAGN price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
MAGN · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 23, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −11%1w ago −2.4%1d ago 0%
Returns since7d30d90d180d1y

Footnotes in full

F1: Because the payout occurred on a Saturday, the value of the shares was determined using the closing price of the previous business day (Friday, November 13, 2026). F2: Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. F3: This 2025 Prorated Director Award vests in full one year from the grant date.